Professional Essentials

  • US Professional News
  • FULLTEXT

Most physicians have been cyberattacked

  • US Professional News
  • FULLTEXT

5 ways to optimize revenue

  • US Professional News
  • FULLTEXT

Embarrassing—but funny—doctor fails

  • US Professional News
  • FULLTEXT

Bankers can help diagnose Alzheimer's

  • US Professional News
  • FULLTEXT

Selling supplements in your office can be lucrative

  • US Professional News
  • FULLTEXT

Boston physician denies harassment allegations

View more

New on Univadis

  • Clinical Essentials from Head Neck
  • 1 comment

HNC: albumin, NLR predict risk for surgical site infection

Study identifies risk factors for local infection after major oncologic surgery.

  • Clinical Essentials from Lancet Oncol
  • 1 comment

BELLE-3: buparlisib combo meets PFS endpoint, with toxicity

Phase 3 data suggest a need for more specific P13K inhibitors.

  • Clinical Essentials from Leuk Lymphoma
  • 1 comment

PCPTL: primary disease site offers prognostic value for survival

Most favorable OS seen in patients with head and neck lesions.

Lung Cancer Vitals for December 2017
  • Vitals
  • 1 comment

Lung Cancer Vitals for December 2017

Modified guidelines for SBRT in NSCLC | Osimertinib vs EGFR-TKIs in NSCLC | FDA approves solid tumor genetic test | FDG-PET unreliable in lung cancer diagnosis.

Prevalence of PE in patients with syncope low | ASH
  • Conference Essentials
  • 1 comment

Prevalence of PE in patients with syncope low | ASH

The prevalence of PE and DVT was 1.1% and 1.4%, respectively.

Diabetes Vitals for December 2017
  • Vitals
  • 1 comment

Diabetes Vitals for December 2017

Metformin and stroke risk | CAC predicts CVD risk in diabetes | What is optimal diabetes screening frequency?

  • Clinical Essentials from J Crohns Colitis
  • 1 comment

IBD: steroids may double venous thromboembolism risk

Anti-TNFα agents, on the other hand, are linked to reduced risk.

  • Clinical Essentials from J Reprod Immunol
  • 1 comment

Lupus: risk factors for pregnancy complications identified

Results of a small study.

  • Clinical Essentials from Ann Intern Med
  • 1 comment

Type 2 diabetes: is individualized glycemic control cost-effective?

Modeling of patient-level data suggests cost, QoL benefits.

  • Clinical Essentials from J Am Heart Assoc
  • 1 comment
  • FULLTEXT

Review of 35 trials finds improved CV outcomes with PCSK9 inhibitors

Treatment may benefit statin-intolerant patients.

  • Clinical Essentials from JAMA Dermatol
  • 1 comment

Melanoma: how does age affect survival with immunotherapy?

Real-world study suggests older age may be tied to better clinical outcome.

  • Clinical Essentials from JAMA Neurol
  • 1 comment

High-intensity exercise shows promise in early Parkinson’s disease

Data from the SPARX phase 2 randomized controlled trial.

  • Clinical Essentials from Cochrane Database Syst Rev
  • 1 comment

Should benzodiazepines be used for psychosis-induced aggression or agitation?

Latest review gives mixed answers.

  • Clinical Essentials from Br J Dermatol
  • 1 comment

Psoriasis: guselkumab yields good results in Japanese study

Data from a small randomized controlled trial.